Biomedical Engineering Reference
In-Depth Information
[166] Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, Sandrin MS, et al. A novel
mechanism of retrovirus inactivation in human serum mediated by anti--galactosyl
natural antibody. J Exp Med 1995;182:1345-55.
[167] Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK. High-titer packaging cells
producing recombinant retroviruses resistant to human serum. J Virol 1995;69:7430-6.
[168] Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, et al.
Inducible, high-level production of infectious murine leukemia retroviral vector parti-
cles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther
1995;6:1203-13.
[169] Miller AD, Chen FC. Retrovirus packaging cells based on 10A1 murine leuke-
mia virus for production of vectors that use multiple receptors for cell entry. J Virol
1996;70:5564-71.
[170] Yu S, Han E, Hong Y, Lee J, Kim S. Construction of a retroviral vector production system
with the minimum possibility of a homologous recombination. Gene Ther 2003;10:706-11.
[171] Kim SH, Yu S, Park JS, Robbins PD, An CS, Kim S. Construction of retroviral vectors
with improved safety, gene expression, and versatility. J Virol 1998;72:994-1004.
[172] Bodine DM, McDonagh KT, Brandt SJ, Ney PA, Agricola B, Byrne E, et al.
Development of a high-titer retrovirus producer cell line capable of gene transfer into
rhesus monkey hematopoietic stem cells. Proc Natl Acad Sci USA 1990;87:3738-42.
[173] Lynch CM, Miller AD. Production of high-titer helper virus-free retroviral vectors by
cocultivation of packaging cells with different host ranges. J Virol 1991;65:3887-90.
[174] Rosenberg SA, Blaese RM, Anderson WF. The N2-TIL human gene transfer protocol.
Hum Gene Ther 1990;1:73-92.
[175] Riddell SR, Elliott M, Lewinsohn DA, Gilbert MJ, Wilson L, Manley SA, et al. T-cell
mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-
infected patients. Nat Med 1996;2:216-23.
[176] Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, et al.
Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine
deaminase deficiency. Nat Med 1995;1:1017-23.
[177] Nabel GJ, Nabel EG, Yang Z-Y, Fox BA, Plautz GE, Gao X, et al. Direct gene transfer
with DNA-liposome complexes in melanoma: expression, biologic activity, lack of tox-
icity in humans. Proc Natl Acad Sci U.S.A. 1993;90:11307-11.
[178] Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF. Gene ther-
apy for the treatment of brain tumors using intra-tumoral transduction with the thymi-
dine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993;4:39-69.
[179] To RY, Booth SC, Neiman PE. Inhibition of retroviral replication by antisense RNA.
Mol Cell Biol 1986;6:4758-62.
[180] Roizman B, Sears A. Herpes simplex viruses and their replication. In: Fields BN, editor.
Fields virology, vol. II. Philadelphia, PA: Raven Press; 1996. p. 2231-95.
[181] Ryan KJ, Ray CG, editor. Sherris medical microbiology. New York, NY: McGraw Hill;
2004. p. 555-62.
[182] Ettenleiter TC, Klupp BG, Granzow H. Herpesvirus assembly: a tale of two membranes.
Curr Opin Microbiol 2006;9:423-29.
[183] McGeoch DJ, Rixon FJ, Davison AJ. Topics in herpesvirus genomics and evolution.
Virus Res 2006;117:90-104.
[184] Rajcáni J, Andrea V, Ingeborg R. Peculiarities of herpes simplex virus (HSV) transcrip-
tion: an overview. Virus Genes 2004;28:293-310.
[185] Ward PL, Roizman B. Herpes simplex genes: the blueprint of a successful human
pathogen. Trends Genet 1994;10:267-74.
Search WWH ::
Custom Search